Deverra Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Deverra Therapeutics's estimated annual revenue is currently $1.2M per year.
- Deverra Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Deverra Therapeutics has 15 Employees.
- Deverra Therapeutics grew their employee count by 67% last year.
Deverra Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and Chief Scientific Officer, EVP Research and Development | Reveal Email/Phone |
2 | President and Co-Founder | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP Manufacturing | Reveal Email/Phone |
5 | VP, Discovery and Translational Research | Reveal Email/Phone |
6 | Director, Clinical Operations | Reveal Email/Phone |
7 | Associate Director Process Development | Reveal Email/Phone |
8 | Director, Cell Biology | Reveal Email/Phone |
9 | Office & Lab Manager | Reveal Email/Phone |
10 | Scientist II | Reveal Email/Phone |
Deverra Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Deverra Therapeutics?
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 15 | -17% | $27.2M |
#2 | $0.5M | 15 | 0% | $7.5M |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $0.5M | 15 | 0% | $8.2M |